Listing Websites about Ariad Pharmaceuticals
ARIAD Pharmaceuticals - Wikipedia
(1 days ago) ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered in Cambridge, Massachusetts. ARIAD engaged in the discovery, development, and commercialization of medicines for cancer … See more
Url: Visit Now
Home - Aria Pharmaceuticals
(2 days ago) WebAria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel, small molecule therapies for patients in need of new treatments across many complicated diseases. These …
Url: Visit Now
FAQ about Ariad Pharmaceuticals
Did Takeda buy ARIAD Pharmaceuticals?
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) (“ARIAD”) for $24.00 per share in cash. “We are very pleased to have completed the acquisition of ARIAD Pharmaceuticals.
What is ARIAD Pharmaceuticals' mailing address?
Ariad Pharmaceuticals' mailing address is 125 Binney St, CAMBRIDGE, MA 02142-1123, United States. The official website for the company is www.ariad.com. The pharmaceutical company can be reached via phone at +1-617-4940400. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.
What is ARIA pharmaceuticals?
Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel, small molecule therapies for patients in need of new treatments across many complicated diseases. These patients simply cannot wait on traditional discovery methods.
What is ARIAD and how does it work?
ARIAD is working on new medicines to advance the treatment of rare forms of chronic and acute leukemia, lung cancer and other rare cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information,...